miRNA Expression Associated with HbF in Saudi Sickle Cell Anemia

Cyrus, Cyril; Vatte, Chittibabu; Al-Nafie, Awatif; Chathoth, Shahanas; Akhtar, Mohammed; Darwish, Mohamed; Almohazey, Dana; AlDubayan, Saud H.; Steinberg, Martin H.; Al-Ali, Amein K.

doi:10.3390/medicina58101470

Cited by 1 publication

(1 citation statement)

References 35 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Patients with high fetal hemoglobin (HbF) status, which is a product of γ-globin genes and modulates SCD, experience fewer painful crises and enhanced survival rates [ 75 ]. Examining the factors that control γ-globin genes at both transcriptional and translational levels, including miRNAs, can assist in the identification of possible therapeutic avenues for SCD [ 76 , 77 ].…”

Section: The Advent Of New Technologiesmentioning

confidence: 99%

Sickle Cell Disease Update: New Treatments and Challenging Nutritional Interventions

Bell,

Varzakas,

Psaltopoulou

et al. 2024

Nutrients

View full text Add to dashboard Cite

Sickle cell disease (SCD), a distinctive and often overlooked illness in the 21st century, is a congenital blood disorder characterized by considerable phenotypic diversity. It comprises a group of disorders, with sickle cell anemia (SCA) being the most prevalent and serious genotype. Although there have been some systematic reviews of global data, worldwide statistics regarding SCD prevalence, morbidity, and mortality remain scarce. In developed countries with a lower number of sickle cell patients, cutting-edge technologies have led to the development of new treatments. However, in developing settings where sickle cell disease (SCD) is more prevalent, medical management, rather than a cure, still relies on the use of hydroxyurea, blood transfusions, and analgesics. This is a disease that affects red blood cells, consequently affecting most organs in diverse manners. We discuss its etiology and the advent of new technologies, but the aim of this study is to understand the various types of nutrition-related studies involving individuals suffering from SCD, particularly in Africa. The interplay of the environment, food, gut microbiota, along with their respective genomes collectively known as the gut microbiome, and host metabolism is responsible for mediating host metabolic phenotypes and modulating gut microbiota. In addition, it serves the purpose of providing essential nutrients. Moreover, it engages in direct interactions with host homeostasis and the immune system, as well as indirect interactions via metabolites. Nutrition interventions and nutritional care are mechanisms for addressing increased nutrient expenditures and are important aspects of supportive management for patients with SCD. Underprivileged areas in Sub-Saharan Africa should be accompanied by efforts to define and promote of the nutritional aspects of SCD. Their importance is key to maintaining well-being and quality of life, especially because new technologies and products remain limited, while the use of native medicinal plant resources is acknowledged.

show abstract

Section: The Advent Of New Technologiesmentioning

confidence: 99%